NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-075-2003-0-EP-06 Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof EP National Stage 04794121.6 Abandoned
NIDDK E-045-2005-0-US-01 METHODS OF USING GLYCOSAMINOGLYCANS FOR THE TREATMENT OF KIDNEY DISEASE US 60/615,472 Abandoned
NCI E-075-2003-0-CA-05 Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof CA National Stage 2539535 Abandoned
NCI E-075-2003-0-AU-04 Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof AU National Stage 2004278782 Abandoned
NCI E-272-2002-0-US-02 Serine Protease Inhibitors US ORD 10/957,266 7439226 Abandoned PDF
NCI E-327-2004-0-US-01 Macrocyclic SH2 Domain Binding Inhibitors US 60/614,800 Abandoned
NCI E-287-2004-0-US-01 IRTA2 ANTIBODIES AND METHODS OF USE US 60/615,406 Abandoned
NIAID E-221-2004-0-US-01 Chondroitin Sulphate A Binding Domains US 60/615,300 Abandoned
NIDDK E-324-2004-0-US-01 In Vitro Model For Hepatitis C Virion Production US 60/615,301 Abandoned
NCI E-316-2003-0-PCT-02 Immunoglobulins With Potent And Broad Antiviral Activity PCT PCT PCT/US2004/31878 Expired
CC E-083-2003-0-PCT-02 Intracellular Trapping Of Radionuclide Mediated By Enzymatic Reduction For Molecular Diagnositc Imaging And Radiotherapy PCT PCT PCT/US2004/031843 Expired
NCI E-316-2003-0-AU-06 Immunoglobulins With Potent And Broad Antiviral Activity AU National Stage 2004321500 Abandoned
NCI E-316-2003-0-CA-04 Immunoglobulins With Potent And Broad Antiviral Activity CA National Stage 2553788 Abandoned
NIMH E-276-2003-0-PCT-02 HIV-Dependent Expression Constructs and Uses Therefore PCT PCT PCT/US2004/031967 Expired
NIMH E-276-2003-0-EP-04 HIV-Dependent Expression Constructs and Uses Therefore EP National Stage 04789246.8 Abandoned
NIMH E-276-2003-0-CA-06 HIV-Dependent Expression Constructs and Uses Therefore CA National Stage 2540253 Abandoned
NIMH E-276-2003-0-AU-05 HIV-Dependent Expression Constructs and Uses Therefor AU National Stage 2004278761 Abandoned
NCI E-240-2001-0-US-04 Macromolecular Imaging Agents For Liver Imaging US National Stage 10/481,706 Abandoned
NCI E-257-2004-0-US-01 Modulating MxA Expression US 60/613,371 Abandoned
NCI E-349-2004-0-US-01 LRATLERIN, RELATED COMPOUNDS AND METHODS OF USE US 60/613,256 Abandoned
NCI E-188-2004-0-US-01 Nitric Oxide Releasing Diazeniumdiolated Derivatives Of Acrylonitrile-containing Polymers US 60/613,257 Abandoned
NIAID E-319-2004-0-US-01 Optimized Vaccines To Provide Protection Against Ebola And Other Viruses US 60/613,883 Abandoned
NCI E-137-2002-0-CA-05 METHOD FOR TREATING CANCER IN HUMANS CA National Stage 2481304 Abandoned
NHLBI E-240-1998-0-US-05 METHOD FOR DETERMINING IN VIVO CONCENTRATION OF A METABOLITE US DIV 10/948,942 7330748 Abandoned PDF
NHLBI E-208-2003-0-PCT-02 Identification Of An Endogenous TACE Inhibitory Peptide (eTIP) PCT PCT PCT/US2004/031608 Expired
NIA E-029-2004-0-US-02 Taste Signaling In Gastrointestinal Cells US National Stage 10/949,751 Abandoned
NCI E-137-2002-0-JP-07 METHOD FOR TREATING CANCER IN HUMANS JP National Stage 2003-579755 Abandoned
NIDCD E-174-2004-1-US-01 Moraxella (or Branhamella) Catarrhalis Is Viable Without Endotoxin, A Potential Vaccine Candidate US 60/613,139 Abandoned
NIA E-183-2003-0-JP-12 Method For Treating Cognitve Disorders JP National Stage 2003-579808 Abandoned
NIA E-183-2003-0-CN-07 Method For Treating Cognitve Disorders CN National Stage 03806681.5 Abandoned
NIA E-183-2003-0-IT-20 Method For Treating Cognitve Disorders IT EP 03723773.2 Abandoned
NIA E-183-2003-0-BE-19 Method For Treating Cognitve Disorders BE EP 03723773.2 Abandoned
NIA E-183-2003-0-ES-21 Method For Treating Cognitve Disorders ES EP 03723773.2 Abandoned
NIA E-183-2003-0-NO-15 Method For Treating Cognitve Disorders NO National Stage 200404530 Abandoned
NIA E-183-2003-0-HR-09 Method For Treating Cognitve Disorders HR National Stage P20040992A Abandoned
NIA E-183-2003-0-MX-14 Method For Treating Cognitve Disorders MX National Stage PA/a/2004/009136 Abandoned
NIAID E-241-2004-0-US-01 Method of Detecting Cancer Based On Immune Reaction To BORIS US 60/611,798 Abandoned
NINDS E-274-2004-0-US-01 Methods of Diagnosing and Treating VHL Associated and Sporadic Renal Cell Carcinoma, and Other VHL Associated and Sporadic Counterpart Tumors Which Co-Express EPO and the EPO Receptor US 60/611,616 Abandoned
NIA E-189-2003-0-CA-15 Thalidomide Analogs AS TNF-ALPHA Modulators CA DIV 2808646 Abandoned
NIA E-189-2003-0-EP-12 Thalidomide Analogs AS TNF-ALPHA Modulators EP National Stage 04784385.9 Abandoned
NIA E-189-2003-0-CA-07 Thalidomide Analogs AS TNF-ALPHA Modulators CA National Stage 2538864 Abandoned
NIA E-189-2003-0-JP-09 Thalidomide Analogs AS TNF-ALPHA Modulators JP National Stage 2006-527059 Abandoned
NIA E-189-2003-0-AU-05 Thalidomide Analogs AS TNF-ALPHA Modulators AU National Stage 2004274474 Abandoned
NHGRI E-020-2003-1-US-02 LMNA GENE AND ITS INVOLVEMENT IN HUTCHINSON-GILFORD PROGERIA SYNDROME (HGPS) AND ARTERIOSCLEROSIS US CON 10/943,400 7297492 Abandoned PDF
NIA E-189-2003-0-SG-13 Thalidomide Analogs AS TNF-ALPHA Modulators SG DIV 200704530-5 Abandoned
NIA E-189-2003-0-PCT-02 Thalidomide Analogs AS TNF-ALPHA Modulators PCT PCT PCT/US2004/30506 Expired
NCI E-315-2003-0-US-02 SH2 Domain Binding Inhibitors US ORD 10/944,699 Abandoned
NIA E-189-2003-0-BR-06 Thalidomide Analogs AS TNF-ALPHA Modulators BR National Stage PI0414497-0 Abandoned
NIEHS E-105-2002-0-US-03 REGULATION OF INS (3456) P4 SIGNALLING BE A REVERSIBLE KINASE/ PHOSPHATASE AND METHODS AND COMPOSITIONS RELATED THERETO US National Stage 10/508,363 Abandoned
NIAID E-335-2003-1-CA-03 HIV Vaccines Based on ENV of Multiple Clades of HIV CA National Stage 2539068 Abandoned